NEW YORK (GenomeWeb News) – CombiMatrix today reported total second-quarter revenue growth of 55 percent, driven by a 421 percent jump in diagnostic services revenue.
 
CombiMatrix said that revenues for the quarter ended June 30 grew to $2.1 million from $1.3 million in the second quarter of 2007.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.